Literature DB >> 23791611

The changes induced by cyclophosphamide in intestinal barrier and microflora in mice.

Jin Yang1, Kai-xiong Liu, Jie-ming Qu, Xiao-dan Wang.   

Abstract

Infection is one of the most commonly encountered complication during chemotherapy treatment, and recent studies showed that such infections are aroused primarily from the intestinal microflora through bacterial translocation. We aimed to investigate the alterations of mucosal barrier and colonization resistance in mouse treated with cyclophosphamide (CTX) to further understand the translocation mechanism. Male Balb/c mice were administered intraperitoneally with CTX at 25 mg/kg, 50 mg/kg and 100 mg/kg for 5 days. We found that pretreatment with CTX, especially at high dose, increased the potentially pathogenic bacteria counts (Escherichia coli, enterobacteraceae, Pseudomonas and enterococci) and the intestinal permeability, which was associated with the reduction of tight junctions and adherens junctions. Our results suggested that disruption of mucosal barrier and colonization resistance may be partly responsible for the bacterial translocation during chemotherapy. Thus, modulation of mechanical mucosal barrier and colonization resistance might represent a new opportunity for applications in cancer patients to reduce infectious complications.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacterial translocation; Cyclophosphamide; Intestinal microflora; Tight junction

Mesh:

Substances:

Year:  2013        PMID: 23791611     DOI: 10.1016/j.ejphar.2013.06.006

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

Review 1.  Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities.

Authors:  Kelley R Jordan; Brett R Loman; Michael T Bailey; Leah M Pyter
Journal:  Cancer       Date:  2018-07-05       Impact factor: 6.860

2.  The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice.

Authors:  Logan B Smith; Michael C Leo; Caroline Anderson; Teresa J Wright; Kristianna B Weymann; Lisa J Wood
Journal:  Brain Behav Immun       Date:  2014-01-08       Impact factor: 7.217

3.  [Changes of intestinal flora in children with acute lymphoblastic leukemia before and after chemotherapy].

Authors:  Sen-Min Chen; Si-Xi Liu; Fen Chen; Chun-Yan Wang; Hui-Rong Mai; Xiu-Li Yuan; Fei-Qiu Wen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

Review 4.  Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora.

Authors:  Hourieh Sadrekarimi; Zhanna R Gardanova; Morteza Bakhshesh; Farnoosh Ebrahimzadeh; Amirhossein Fakhre Yaseri; Lakshmi Thangavelu; Zahra Hasanpoor; Firoozeh Abolhasani Zadeh; Mohammad Saeed Kahrizi
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

5.  Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment.

Authors:  Nai-Lun Yeh; Che-Yuan Hsu; Tsen-Fang Tsai; Hsien-Yi Chiu
Journal:  Clin Drug Investig       Date:  2019-12       Impact factor: 2.859

6.  The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.

Authors:  Sophie Viaud; Fabiana Saccheri; Grégoire Mignot; Takahiro Yamazaki; Romain Daillère; Dalil Hannani; David P Enot; Christina Pfirschke; Camilla Engblom; Mikael J Pittet; Andreas Schlitzer; Florent Ginhoux; Lionel Apetoh; Elisabeth Chachaty; Paul-Louis Woerther; Gérard Eberl; Marion Bérard; Chantal Ecobichon; Dominique Clermont; Chantal Bizet; Valérie Gaboriau-Routhiau; Nadine Cerf-Bensussan; Paule Opolon; Nadia Yessaad; Eric Vivier; Bernhard Ryffel; Charles O Elson; Joël Doré; Guido Kroemer; Patricia Lepage; Ivo Gomperts Boneca; François Ghiringhelli; Laurence Zitvogel
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

Review 7.  Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment.

Authors:  Andrea Botticelli; Ilaria Zizzari; Federica Mazzuca; Paolo Antonio Ascierto; Lorenza Putignani; Luca Marchetti; Chiara Napoletano; Marianna Nuti; Paolo Marchetti
Journal:  Oncotarget       Date:  2017-01-31

Review 8.  A Potential Adjuvant Agent of Chemotherapy: Sepia Ink Polysaccharides.

Authors:  Fangping Li; Ping Luo; Huazhong Liu
Journal:  Mar Drugs       Date:  2018-03-28       Impact factor: 5.118

Review 9.  Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.

Authors:  Concetta Panebianco; Angelo Andriulli; Valerio Pazienza
Journal:  Microbiome       Date:  2018-05-22       Impact factor: 14.650

10.  The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells.

Authors:  Michal P Kuczma; Zhi-Chun Ding; Tao Li; Tsadik Habtetsion; Tingting Chen; Zhonglin Hao; Locke Bryan; Nagendra Singh; James N Kochenderfer; Gang Zhou
Journal:  Oncotarget       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.